Navigation Links
Mettler Toledo Presents In-depth Guidance to Comply with New USP Chapters 41 and 1251 on Balances Used for Quantitative Analysis in the Pharma QC Lab

LONDON, September 4, 2012 /PRNewswire/ --

USP published their long awaited new drafts to revise the General Chapters 41 "Balances" and 1251 "Weighing on an Analytical Balance" in the Pharmacopeial Forum PF 38(5).

The new drafts are intended to replace the existing chapters and provide a more user-friendly option for the determination of minimum weight. The documents also propose a risk-based approach to determine type and frequency of routine tests, with the omission of daily balance checks from the drafts in accordance with current FDA thinking.

In response to the updated drafts, Dr Klaus Fritsch, Manager Compliance, Global Business Area Laboratory & Weighing Technologies at METTLER TOLEDO presents a contemporary strategy for best-practice compliance with these new guidelines following Good Weighing Practice™; the global Weighing Standard.

In addition to his role at METTLER TOLEDO, Dr Fritsch frequently consults the industry to help achieve compliance with applicable regulations when using weighing systems. He has been actively involved on committees including the USP Expert Panel to revise the General Chapters 41 and 1251.

In his presentation, Dr Fritsch explains how these revised chapters affect balance quality management and applicable SOPs, especially in the framework of determining minimum weight and executing routine testing.

Session highlights:

  • In depth information on the new requirements of the draft to change USP General Chapter 41 "Balances"
  • Which tests have to be periodically performed on balances used for quantitative analysis and which acceptance criteria apply
  • The two alternatives to assess and calculate the minimum weight of your balances
  • Insight into the risk-based approach to performing balance routine testing as recommended by USP General Chapter 1251 "Weighing on an Analytical Balance"
  • The proper weight selection for balance routine testing
  • Why the General Chapters no longer talk about daily balance checks

The full presentation can be viewed exclusively at Pharma IQ now:

Editors Notes

About GWP

GWP® is the only science-based global standard for efficient lifecycle management of weighing systems, developed from the expertise of METTLER TOLEDO. Lifecycle management according to GWP consists of evaluation, selection, installation, calibration and routine operation. GWP is applicable to all kinds of weighing systems of any manufacturer!

Based on the sound scientific principles of the global weighing standard, METTLER TOLEDO offers two unique commercial services: GWP® Verification & GWP® Recommendation. Service offerings, which guarantee consistent weighing accuracy, audit readiness and feasible cost efficiency, encompassing the entire lifecycle of the weighing equipment

About Mettler Toledo

METTLER TOLEDO is a global manufacturer and marketer of precision instruments for use in laboratory, industrial and food retailing applications. The Company has strong worldwide leadership positions. A significant majority of METTLER TOLEDO instrument sales are in segments in which METTLER TOLEDO is the global leader. In addition to a broad product offering, METTLER TOLEDO has one of the largest global sales and service organizations among precision instrument companies.

About Pharma IQ

Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical professionals with knowledge, information and articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community.

Pharma IQ and IQPC provide useful training courses, conference and expositions for pharmaceutical executives to network and learn the latest pharma business development and trends occurring in organizations today. Pharma IQ focuses on establishing an interactive experience featuring practical, objective and up-to-date insight from pharma industry leaders.

About IQPC

IQPC Ltd has an established reputation for delivering the highest standard of industry specific conferences, seminars and internal training programmes. We aim to keep business executives up-to date with the forefront of their industries' trends, technological developments and regulatory landscape.

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
3. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
4. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
5. Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive Disease Week ®
6. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
7. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
8. Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting
9. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
10. Berg Pharma presents at ASCO, poised to lead field in cancer metabolism with Phase II trials of BPM 31510
11. This Week: UBM Canon Presents an Online Event and Conference Dedicated to Emerging Trends in Medical Device Outsourcing/Contract Manufacturing
Post Your Comments:
(Date:10/12/2015)... 2015 Given the intricacy of the ... to deliver an ophthalmic drug effectively to a specific ocular ... ocular drug delivery. These include dilution of a drug by ... conjunctiva and drug permeation issues with respect to the cornea, ... eye drops, is lost due to the aforementioned barriers. ...
(Date:10/12/2015)... N.J. , Oct. 12, 2015  Shareholder rights ... a securities fraud class action complaint was filed in ... Jersey.  The complaint alleges that officers and directors of ... Act of 1934 between September 15, 2015 and October ... about Amicus Therapeutics, business prospects.  Amicus is a biopharmaceutical ...
(Date:10/12/2015)... 12, 2015  Millions of smokers worldwide have used ... of tobacco. An April 2015 study released ... showed electronic cigarettes to be up to 95 percent ... a decade after the technology was first introduced the ... --> --> Palm ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... 2015 , ... Tempe Dental Care, a leading Tempe dentists’ office, celebrates offering ... dentistry for more than 5 years. A leading cause of emergency room visits, ... treatment is not timely. , Sedation dentistry provides an anxiety-free dental ...
(Date:10/13/2015)... ... ... According to an ESPN report published on October 1, Chicago ... him in the left eye during the first day of practice for the season ... of setbacks, including a knee injury that has interfered with his ability to stay ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... developed valuable new strategies for enrolling and serving insurance consumers who do not ... health insurance and pay monthly premiums. In “Health Plan Engagement Strategies: The ABCs ...
(Date:10/13/2015)... ... October 13, 2015 , ... Just under three months ... eMarketing Concepts began a $1 promotion – effectively offering all of their services for ... within weeks the company was flooded with phone calls from interested buyers. As a ...
(Date:10/13/2015)... ... , ... The Bill Howe Family of Companies is an award winning HVAC ... remediation services. Family-owned and operated for 35 years, they have maintained value, ethics and ... two years in a row from the Union Tribune Reader’s Poll, a Healthiest Company ...
Breaking Medicine News(10 mins):